Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Int.biotech. (IBT) Share Price

Price 1,130.00p on 25-08-2026 at 18:05:09
Change 25.00p 2.26%
Buy 1,130.00p
Sell 1,125.00p
Last Trade: Unknown 5,044.00 at 1,130.00p
Day's Volume: 82,651
Last Close: 1,130.00p
Open: 1,105.00p
ISIN: GB0004559349
Day's Range 1,105.00p - 1,130.00p
52wk Range: 670.00p - 1,215.00p
Market Capitalisation: £358.24m
VWAP: 1,119.37812p
Shares in Issue: 31.70m

Int.biotech. (IBT) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Unknown* 5,044 1,130.00p OTC Trade
17:05:38 - 25-Aug-26
Buy* 166 1,130.00p Suspected BUY Trade
16:35:13 - 25-Aug-26
Unknown* 0 1,130.00p SI Trade
16:18:49 - 25-Aug-26
Buy* 13 1,130.00p SI Trade
16:18:49 - 25-Aug-26
Buy* 13 1,130.00p Automatic Execution
16:18:49 - 25-Aug-26
Buy* 325 1,129.25p Ordinary
16:02:33 - 25-Aug-26
Unknown* 10,950 1,130.00p Ordinary
15:58:34 - 25-Aug-26
Unknown* -10,000 1,130.00p Ordinary
Correction
15:58:34 - 25-Aug-26
Buy* 10,000 1,130.00p Ordinary
15:58:34 - 25-Aug-26
Buy* 354 1,129.2475p Ordinary
15:55:16 - 25-Aug-26
See more Int.biotech. trades

Int.biotech. (IBT) Share Price History

Time period:
to
Date Open High Low Close Volume
24th Aug 2026 (Mon) 1,110.00 1,125.00 1,100.00 1,105.00 77,108
21st Aug 2026 (Fri) 1,125.00 1,125.00 1,115.00 1,120.00 184,369
20th Aug 2026 (Thu) 1,135.00 1,135.00 1,110.00 1,130.00 80,193
19th Aug 2026 (Wed) 1,105.00 1,135.00 1,105.00 1,130.00 102,262
18th Aug 2026 (Tue) 1,085.00 1,105.00 1,085.00 1,105.00 60,920
17th Aug 2026 (Mon) 1,090.00 1,090.00 1,085.00 1,085.00 98,095
14th Aug 2026 (Fri) 1,090.00 1,090.00 1,070.00 1,075.00 33,740
13th Aug 2026 (Thu) 1,090.00 1,100.00 1,085.00 1,085.00 42,088
12th Aug 2026 (Wed) 1,085.00 1,090.00 1,085.00 1,090.00 34,758
11th Aug 2026 (Tue) 1,105.00 1,105.00 1,085.00 1,085.00 41,170
10th Aug 2026 (Mon) 1,095.00 1,105.00 1,095.00 1,100.00 73,212
7th Aug 2026 (Fri) 1,075.00 1,095.00 1,075.00 1,090.00 39,988
6th Aug 2026 (Thu) 1,055.00 1,085.00 1,055.00 1,075.00 45,743
5th Aug 2026 (Wed) 1,050.00 1,060.00 1,050.00 1,050.00 39,923
4th Aug 2026 (Tue) 1,035.00 1,045.00 1,035.00 1,045.00 65,055
3rd Aug 2026 (Mon) 1,020.00 1,045.00 1,020.00 1,020.00 58,027
31st Jul 2026 (Fri) 1,030.00 1,055.00 1,020.00 1,020.00 40,745
30th Jul 2026 (Thu) 1,065.00 1,065.00 1,035.00 1,040.00 83,829
29th Jul 2026 (Wed) 1,070.00 1,085.00 1,070.00 1,070.00 44,074
28th Jul 2026 (Tue) 1,080.00 1,080.00 1,070.00 1,070.00 54,278
27th Jul 2026 (Mon) 1,085.00 1,100.00 1,080.00 1,080.00 52,580
See more Int.biotech. price history

Int.biotech. (IBT) Regulatory News

Date Source Headline
24th Aug 2026 11:07 am RNS Net Asset Value(s)
21st Aug 2026 11:25 am RNS Net Asset Value(s)
20th Aug 2026 11:46 am RNS Net Asset Value(s)
19th Aug 2026 11:29 am RNS Net Asset Value(s)
18th Aug 2026 11:37 am RNS Net Asset Value(s)
17th Aug 2026 11:14 am RNS Net Asset Value(s)
14th Aug 2026 11:39 am RNS Net Asset Value(s)
13th Aug 2026 10:56 am RNS Net Asset Value(s)
12th Aug 2026 11:04 am RNS Net Asset Value(s)
11th Aug 2026 12:00 pm RNS Net Asset Value(s)
See more Int.biotech. regulatory news

Int.biotech. (IBT) Share News

UK dividends calendar - next 7 days

14th Aug 2026 12:57

Read More

UK dividends calendar - next 7 days

16th Jul 2026 14:44

Read More

IBT company Crinetics to be acquired by Vertex for USD10 billion

7th Jul 2026 19:11

(Alliance News) - International Biotechnology Trust PLC on Tuesday said its portfolio company, Crinetics Pharmaceuticals Inc, entered a deal to be acquired by Vertex Pharmaceuticals Inc in a deal worth USD10 billion. Read More

IN BRIEF: International Biotech highlights deal for investee Apogee

22nd Jun 2026 20:07

International Biotechnology Trust PLC - invests in biotechnology companies - Notes announcement that investee company Apogee Therapeutics is to be acquired by AbbVie Inc. Apogee shareholders will receive USD135.11 per share in cash at closing. As at close of business on Friday, Apogee represented around 0.41% of IBT's net asset value. IBT Portfolio Managers Ailsa Craig and Marek Poszepczynski say: "The biotech M&A boom shows no signs of slowing, with deal flow running ahead of last year's pace. The latest deal represents the seventh acquisition within the IBT portfolio in 2026 so far, compared to three acquisitions at the same stage last year, with the total value of the companies acquired also up 9%. This demonstrates the success of our investment strategy." Read More

EARNINGS: Griffin Mining revenue jumps; Andrews Sykes holds payout

12th May 2026 12:48

(Alliance News) - The following is a round-up of earnings for London-listed companies, issued on Tuesday and not separately reported by Alliance News: Read More

See more Int.biotech. news
FTSE 100 Latest
Value10,886.16
Change31.84

Login to your account

Forgot Password?

Not Registered